Current status of liver transplantation for adult patients with acute-on-chronic liver failure.
10.3760/cma.j.cn112139-20210810-00369
- Author:
Ruo Lin WU
1
;
Hong Chuan ZHAO
1
;
Xiao Ping GENG
1
Author Information
1. Department of General Surgery,the First Affiliated Hospital of Anhui Medical Univeristy,Hefei 230022,China.
- Publication Type:Journal Article
- MeSH:
Acute-On-Chronic Liver Failure/surgery*;
Adult;
Humans;
Liver Cirrhosis;
Liver Transplantation;
Prognosis;
Prospective Studies;
Waiting Lists
- From:Chinese Journal of Surgery
2022;60(2):181-187
- CountryChina
- Language:Chinese
-
Abstract:
Acute-on-chronic liver failure(ACLF) is the most severe form of acute decompensation that develops in patients with chronic liver disease or liver cirrhosis,and is always accompanied by one or more extrahepatic organ failure, and has an extremely poor short-term prognosis. The causes triggering ACLF are complex and diverse,and the clinical stage and the type and the definition of organ failure differ greatly from one another. Therefore, a universally accepted diagnostic criteria for ACLF is not to be defined, and the epidemiological data and patient outcomes on ACLF are not easy to predict and compare among different regions. Accumulating evidence has shown that liver transplantation(LT) plays a significant role in the surgical treatment of patients with ACLF,but its clinical value is still controversial. The specific management and treatment strategy after the admission of patients with ACLF has not yet formed a unified and standardized process or opinions, which includes the monitoring in the ICU,the support and maintenance of organ functions, the selection of the surgical indication and the timing for LT and so on. Moreover, there still exists many controversies concerning, for example, whether patients with ACLF should receive greater priority for organ allocation compared to other potential candidates on the waiting list. Besides, more prospective controlled studies are urgently needed to investigate the role of the artificial liver support system in the bridging therapy to LT. The aim of this article is to review the indication selection of patients with ACLF suitable for LT,the survival outcomes and prognostic factors after LT, the selection of timing, the organ allocation policy and the bridging therapy to LT, which intends to provide new direction for designing the future clinical studies on LT in patients with ACLF.
